Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
1
x
$
30.00
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders
1
x
$
30.00
Teaching Monograph Grand Round Series: Quality-of-Life and Pharmacoeconomic Considerations of Obsessive-Compulsive Disorder
1
x
$
10.00
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF)
1
x
$
0.00
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
1
x
$
30.00
View Cart
Checkout
Home
schizophrenia
“Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
$
30.00
Add to cart
Details
Paliperidone Induced Hypothyroidism: A Case Report
$
30.00
Add to cart
Details
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
$
30.00
Add to cart
Details
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
$
30.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
$
30.00
Add to cart
Details
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
$
30.00
Add to cart
Details
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Exercise as a Treatment for Schizophrenia: A Review
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 2, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
$
0.00
Add to cart
Details
Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
$
30.00
Add to cart
Details
1
2
…
4
Next
Page load link
Go to Top
